Inventor · Oneonta, NY, US

John P. Ford

41Patents
11h-index
36Co-inventors
75Inventor score

Filing activity: Jul 25, 1984 → Nov 10, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7456187B2 Furanopyrimidine compounds as potassium ion channel inhibitors Human Necessities 33 Expired
US9286443B2 Systems and methods for data aggregation and prioritization Physics 27 Active
US4617102A Process and apparatus for purifying and concentrating DNA from crude mixtures containing DNA Performing Operations; Transporting 27 Expired
US4794075A Method for locating and purifying DNA containing single base mismatches Emerging Cross-Sectional Technologies 23 Expired
US4895955A Non-radioactive carbodiimide precursor to nucleic acid probes Emerging Cross-Sectional Technologies 18 Expired
US6979688B2 Treatment method against side-effects of chemotherapy Human Necessities 17 Expired
US8022076B2 Substituted thieno[2,3-d]pyrimidines as potassium channel inhibitors Chemistry; Metallurgy 16 Expired
US6995165B2 Methods, compositions, and kits for organ protection during systemic anticancer therapy Human Necessities 14 Expired
US4775745A Diazonium compounds useful as components for nucleic acid probes Emerging Cross-Sectional Technologies 13 Expired
US7368456B2 Methods, compositions, and kits for organ protection during systemic anticancer therapy Human Necessities 12 Expired
US7662829B2 Methods, compositions, and kits for organ protection during systemic anticancer therapy Human Necessities 11 Active
US9249155B2 Thieno [2, 3-D] pyrimidine derivatives and their use to treat arrhythmia Human Necessities 11 Active
US4750982A Process and apparatus for purifying and concentrating DNA from crude mixtures containing DNA Performing Operations; Transporting 9 Expired
US7816366B2 Compositions and methods for treating and preventing dermatoses Human Necessities 8 Active
US8258147B2 Compositions and methods for treating and preventing dermatoses Human Necessities 7 Active
US7812030B2 Methods, compositions, and kits for organ protection during systemic anticancer therapy Human Necessities 7 Active
US8653090B2 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents Human Necessities 7 Active
US9119855B2 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents Human Necessities 6 Active
US9084788B2 Compositions and methods for treating and preventing dermatoses Human Necessities 6 Active
US8489544B2 System and method for prioritization and display of aggregated data Physics 6 Active
US10300059B2 Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors Human Necessities 6 Active
US10736557B2 Methods and magnetic imaging devices to inventory human brain cortical function Physics 5 Active
US11013742B2 Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases Human Necessities 4 Active
US4721668A Pre-electrophoretic nucleic acid hybridization Chemistry; Metallurgy 4 Expired
US10653692B2 Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases Human Necessities 4 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.